| 1110 |
decreased |
cellular response to oxidative stress
(GO:0034599)
|
|
1869: Diminished protective oxidative stress response
|
| 1109 |
increased |
Metaplasia
(MESH:D008679)
|
endometrium epithelium
(UBERON:0004811)
|
1068: Endometrial squamous metaplasia, Increase
|
| 1108 |
increased |
Endometrial carcinoma
(HP:0012114)
|
adenosquamous carcinoma
(MESH:D018196)
|
1070: Increased, adenosquamous carcinomas of endometrium
|
| 1107 |
increased |
Metaplasia
(MESH:D008679)
|
Squamous cell
(FMA:66769)
|
2 Events
|
| 1106 |
abnormal |
cell differentiation
(GO:0030154)
|
cell
(GO:0005623)
|
1560: Cell differentiation, altered
|
| 1105 |
increased |
receptor agonist activity
(GO:0048018)
|
estrogen receptor
(PR:000007204)
|
111: Agonism, Estrogen receptor
|
| 1104 |
increased |
increased synaptic depression
(MP:0002916)
|
CNS neuron (sensu Vertebrata)
(CL:0000117)
|
1944: Synaptic dysfunction
|
| 1103 |
increased |
|
homeobox protein SIX1
(PR:000014896)
|
None
|
| 1102 |
increased |
regulation of actin-dependent ATPase activity
(GO:1904621)
|
actin cytoskeleton
(GO:0015629)
|
2078: Loss of drebrin
|
| 1101 |
decreased |
dendritic spine morphogenesis
(GO:0060997)
|
actin cytoskeleton
(GO:0015629)
|
2078: Loss of drebrin
|
| 1100 |
increased |
NMDA glutamate receptor activity
(GO:0004972)
|
|
None
|
| 1099 |
increased |
abnormal long term potentiation
(MP:0002207)
|
drebrin
(PR:000006296)
|
2242: Abnormality, dendritic spine morphology
|
| 1098 |
decreased |
long term synaptic depression
(GO:0060292)
|
drebrin
(PR:000006296)
|
2242: Abnormality, dendritic spine morphology
|
| 1097 |
decreased |
Dementia
(HP:0000726)
|
drebrin
(PR:000006296)
|
2242: Abnormality, dendritic spine morphology
|
| 1096 |
increased |
palatal shelves fail to meet at midline
(MP:0009888)
|
secondary palate
(UBERON:0001716)
|
2041: Decrease, facial prominence outgrowth
|
| 1095 |
increased |
palatal shelves fail to meet at midline
(MP:0009888)
|
primary palate
(UBERON:0005620)
|
2041: Decrease, facial prominence outgrowth
|
| 1094 |
decreased |
ovarian follicle development
(GO:0001541)
|
granulosa cell
(CL:0000501)
|
1800: Granulosa cell proliferation of gonadotropin-independent follicles, Reduced
|
| 1093 |
decreased |
androgen receptor signaling pathway
(GO:0030521)
|
androgen receptor
(PR:000004191)
|
None
|
| 1092 |
arrested |
androgen receptor signaling pathway
(GO:0030521)
|
androgen receptor
(PR:000004191)
|
None
|
| 1091 |
increased |
cell death
(GO:0008219)
|
cell
(GO:0005623)
|
1825: Increase, Cell death
|
| 1090 |
decreased |
response to odorant
(GO:1990834)
|
Nose
(FMA:46472)
|
2317: Loss of olfactory function
|
| 1089 |
increased |
Pulmonary edema
(HP:0100598)
|
lung
(UBERON:0002048)
|
2316: Increased, pulmonary edema
|
| 1088 |
decreased |
decreased neurotransmitter release
(MP:0003990)
|
CNS neuron (sensu Vertebrata)
(CL:0000117)
|
1944: Synaptic dysfunction
|
| 1087 |
decreased |
Premature ovarian failure
(HP:0008209)
|
ovarian follicle
(UBERON:0001305)
|
2305: Premature ovarian Insufficiency
|
| 1086 |
decreased |
cytochrome-c oxidase activity
(GO:0004129)
|
mitochondrion
(GO:0005739)
|
1840: Inhibition, cytochrome oxidase
|